Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L DEWEY

Showing results (401-410 of 460) with videos related to

Pageof 46
Sort By:
Synapse (New York, N.Y.)|May 1, 1992
Regional distribution and kinetics of haloperidol binding in human brain: a PET study with [18F]haloperidolD J Schlyer, N D Volkow, J S Fowler, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 7, 2015
Morphine Tolerance and Physical Dependence Are Altered in Conditional HIV-1 Tat Transgenic MiceSylvia Fitting, David L Stevens, Fayez A Khan, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1994
Diminished cerebral metabolic response to motor stimulation in schizophrenics: a PET studyW Guenther, J D Brodie, E J Bartlett, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 15, 2014
Regional brain metabolism in a murine systemic lupus erythematosus modelAn Vo, Bruce T Volpe, Chris C Tang, et al.
The American Journal of Psychiatry|May 1, 1994
Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjectsE J Bartlett, J D Brodie, P Simkowitz, et al.
Synapse (New York, N.Y.)|December 1, 1996
Mapping nicotinic acetylcholine receptors with PETY S Ding, S J Gatley, J S Fowler, et al.
Journal of Medicinal Chemistry|October 23, 2013
Design, synthesis, and biological evaluation of 14-heteroaromatic-substituted naltrexone derivatives: pharmacological profile switch from mu opioid receptor selectivity to mu/kappa opioid receptor dual selectivityYunyun Yuan, Saheem A Zaidi, Orgil Elbegdorj, et al.
ACS Chemical Neuroscience|July 21, 2012
Characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives as novel leads to development of mu opioid receptor selective antagonistsYunyun Yuan, Guo Li, Hengjun He, et al.
Science (New York, N.Y.)|August 4, 1972
Water-soluble derivatives of 1 -tetrahydrocannabinolB A Zitko, J F Howes, R K Razdan, et al.
ACS Chemical Neuroscience|April 30, 2026
Structural Determinants of μ-Opioid Receptor Antagonism and Respiratory Liability in Phenylfentanyl AnaloguesEnnian Li, Balaji S Kale, Abeje A Silte, et al.
Pageof 46

Showing results (401-410 of 460) with videos related to

Sort By:
Pageof 46
Synapse (New York, N.Y.)|May 1, 1992
Regional distribution and kinetics of haloperidol binding in human brain: a PET study with [18F]haloperidolD J Schlyer, N D Volkow, J S Fowler, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 7, 2015
Morphine Tolerance and Physical Dependence Are Altered in Conditional HIV-1 Tat Transgenic MiceSylvia Fitting, David L Stevens, Fayez A Khan, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1994
Diminished cerebral metabolic response to motor stimulation in schizophrenics: a PET studyW Guenther, J D Brodie, E J Bartlett, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 15, 2014
Regional brain metabolism in a murine systemic lupus erythematosus modelAn Vo, Bruce T Volpe, Chris C Tang, et al.
The American Journal of Psychiatry|May 1, 1994
Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjectsE J Bartlett, J D Brodie, P Simkowitz, et al.
Synapse (New York, N.Y.)|December 1, 1996
Mapping nicotinic acetylcholine receptors with PETY S Ding, S J Gatley, J S Fowler, et al.
Journal of Medicinal Chemistry|October 23, 2013
Design, synthesis, and biological evaluation of 14-heteroaromatic-substituted naltrexone derivatives: pharmacological profile switch from mu opioid receptor selectivity to mu/kappa opioid receptor dual selectivityYunyun Yuan, Saheem A Zaidi, Orgil Elbegdorj, et al.
ACS Chemical Neuroscience|July 21, 2012
Characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives as novel leads to development of mu opioid receptor selective antagonistsYunyun Yuan, Guo Li, Hengjun He, et al.
Science (New York, N.Y.)|August 4, 1972
Water-soluble derivatives of 1 -tetrahydrocannabinolB A Zitko, J F Howes, R K Razdan, et al.
ACS Chemical Neuroscience|April 30, 2026
Structural Determinants of μ-Opioid Receptor Antagonism and Respiratory Liability in Phenylfentanyl AnaloguesEnnian Li, Balaji S Kale, Abeje A Silte, et al.
Pageof 46